Cameron William Lawrence serves as Executive at ONCOGENEX PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Cameron William Lawrence has executed 6 insider transactions totaling $19.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 25, 2020 involved receiving (via award) 19,647 shares valued at $0.
Cameron William Lawrence currently holds 96,208 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cameron William Lawrence has been a net buyer of OGXI stock. They have purchased $19.5K and sold $0 worth of shares.
Cameron William Lawrence's most recent insider trade was on Mar 25, 2020, when they sold 19,647 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 13, 2019 | GNC | $9.3K | Purchase | 5,000 | $1.86 | Discretionary |
| Feb 22, 2011 | OGXI | $1.4K | Option Exercise | 475 | $3.00 | Discretionary |
| Feb 22, 2011 | OGXI | $4.2K | Option Exercise | 1,400 | $3.00 | Discretionary |
| Nov 9, 2010 | OGXI | $10.2K | Purchase | 650 | $15.73 | Discretionary |